$28.86
-1.18 (-3.93%)
Open$29.75
Previous Close$30.04
Day High$30.00
Day Low$28.70
52W High$40.22
52W Low$12.75
Volume—
Avg Volume953.8K
Market Cap2.10B
P/E Ratio—
EPS$-2.83
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+73.8% upside
Current
$28.86
$28.86
Target
$50.17
$50.17
$29.72
$50.17 avg
$68.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 226.08M | 323.22M | 315.22M |
| Net Income | -8,443,102 | -37,471,003 | -43,595,472 |
| Profit Margin | -3.7% | -11.6% | -13.8% |
| EBITDA | -23,071,522 | -52,091,948 | -53,358,586 |
| Free Cash Flow | — | -52,998,459 | -42,607,892 |
| Rev Growth | +145.9% | +14.4% | -1.8% |
| Debt/Equity | — | 0.58 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |